Kapcala L P, Hamilton S M, Meikle A W
Arch Intern Med. 1984 Mar;144(3):636-7.
Suppression of urinary corticosteroids during low-dose dexamethasone testing (0.5 mg every six hours eight times) has commonly been recognized as a response that excludes the diagnosis of Cushing's syndrome. Although "normal suppression" has been reported previously in Cushing's disease, rarely has an explanation been provided for this aberrant response. We report a case of proven Cushing's disease in which normal suppression was observed with low-dose dexamethasone testing. Further study suggested that this phenomenon, which is not widely recognized, was related to an abnormally decreased clearance of dexamethasone. We therefore suggest that whenever responses to testing appear discordant with the clinical index of suspicion, simultaneous plasma dexamethasone and cortisol levels should be obtained to exclude abnormalities in dexamethasone clearance.
在小剂量地塞米松试验(每6小时0.5毫克,共8次)期间尿皮质类固醇的抑制通常被认为是一种排除库欣综合征诊断的反应。尽管之前曾报道库欣病患者存在“正常抑制”情况,但很少有人对这种异常反应作出解释。我们报告了一例经证实的库欣病病例,该病例在小剂量地塞米松试验中观察到正常抑制。进一步研究表明,这种未被广泛认识的现象与地塞米松清除率异常降低有关。因此,我们建议,每当检测结果与临床怀疑指标不一致时,应同时检测血浆地塞米松和皮质醇水平,以排除地塞米松清除异常的情况。